Castle Biosciences, Inc. (CSTL)
32.03
-1.77
(-5.24%)
USD |
NASDAQ |
Oct 16, 15:19
Castle Biosciences Cash from Investing (Quarterly) : -15.96M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.96M |
| March 31, 2026 | -25.80M |
| December 31, 2025 | 8.831M |
| September 30, 2025 | -18.39M |
| June 30, 2025 | -28.38M |
| March 31, 2025 | -22.43M |
| December 31, 2024 | 5.77M |
| September 30, 2024 | -14.79M |
| June 30, 2024 | -21.42M |
| March 31, 2024 | -19.70M |
| December 31, 2023 | -7.672M |
| September 30, 2023 | -9.708M |
| June 30, 2023 | -15.39M |
| March 31, 2023 | 16.58M |
| December 31, 2022 | -4.482M |
| September 30, 2022 | -134.15M |
| June 30, 2022 | -27.51M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.402M |
| December 31, 2021 | -30.89M |
| September 30, 2021 | -0.923M |
| June 30, 2021 | -34.10M |
| March 31, 2021 | -0.75M |
| December 31, 2020 | -0.588M |
| September 30, 2020 | -1.904M |
| June 30, 2020 | -1.756M |
| March 31, 2020 | -0.50M |
| December 31, 2019 | -0.3473M |
| September 30, 2019 | -0.1652M |
| June 30, 2019 | -0.1808M |
| March 31, 2019 | -0.2436M |
| December 31, 2018 | |
| September 30, 2018 | -0.087M |
| June 30, 2018 | -0.156M |
| March 31, 2018 | -0.0286M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| RadNet, Inc. | -63.55M |
| Lumexa Imaging Holdings, Inc. | -13.64M |
| Quest Diagnostics, Inc. | -134.00M |
| Labcorp Holdings, Inc. | -366.20M |
| OPKO Health, Inc. | 15.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 15.20M |
| Cash from Financing (Quarterly) | -0.886M |
| Free Cash Flow | -0.489M |
| Free Cash Flow Per Share (Quarterly) | 0.2155 |
| Free Cash Flow to Equity (Quarterly) | 6.625M |
| Free Cash Flow to Firm (Quarterly) | 6.786M |
| Free Cash Flow Yield | -0.05% |